The American Journal of Medicine
Volume 102, Issue 3 , Pages 245-251 , March 1997

Coronary vasomotor reactivity among normotensive african and white american subjects with chest pain

Received 19 August 1996 ,Revised 22 November 1996

References 

  1. Cooper ES, Celer LH, Saunders E, et al. Cardiovascular diseases and stroke in African Americans and other racial minorities in the United States: A statement for health professionals. Circulation. 1991;83:1462–1480
  2. Gillum RF. Cardiovascular disease in the United States: An epidemiologic overview. In: Saunders E editors. Cardiovascular Diseases in Blacks. Philadelphia: FA Davis; 1991;p. 1–16
  3. Freedman DS, Gruchow H, Manley JC, et al. Black/white differences in risk factors for arteriographically documented coronary artery disease in men. Am J Cardiol. 1988;62:214–219
  4. Sempos C, Cooper R, Kovar M, McMillen M. Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health. 1988;78:1422–1427
  5. Freedman DS, Strogatz DS, Eaker E, et al. Differences between black and white men in correlates of high-density lipoprotein cholesterol. Am J Epidemiol. 1990;132:656–669
  6. Guyton JR, Dahlen GH, Patsch W, et al. Relationship of plasma lipoprotein Lp (a) levels to race and to apolipoprotein B. Arteriosclerosis. 1985;5:265–272
  7. Houghton JL, Prisant LM, Carr AA, et al. Racial differences in myocardial ischemia and coronary flow reserve in hypertension. J Am Coll Cardiol. 1994;23:1123–1129
  8. Abstract Panza JA, Garcia CE, Kilcoyne CM, et al. Impaired endothelium-dependent vasodilation in patients with essential hypertension: Evidence for a generalized endothelial abnormality. J Am Coll Cardiol. 1994;23:274A
  9. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 1994;23:833–843
  10. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age related decline in women. J Am Coll Cardiol. 1994;24:471–476
  11. Antony I, Nitenberg A, Foult JM, Aptecar E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol. 1993;22:514–520
  12. Brush J, Faxon D, Salmon S, et al. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol. 1992;19:809–815
  13. Treasure CB, Klein L, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993;87:86–93
  14. Creager M, Cooke J, Mendelsohn M. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228–234
  15. Drexler H, Zeiher A, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546–1550
  16. Zeiher A, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391–401
  17. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 1987;80:1808–1811
  18. Herrington DM, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 1994;73:951–952
  19. Vita J, Treasure C, Nabel E, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491–497
  20. Quillen JE, Rossen JD, Oskarsson HJ, et al. Acute effect of cigarette smoking on the coronary circulation: Constriction of epicardial and resistance vessels. J Am Coll Cardiol. 1993;22:642–647
  21. Havranek EP, Nademance K, Grayburn PA, Eichhorn EJ. Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy. J Am Coll Cardiol. 1996;28:1168–1174
  22. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature. 1993;362:801–809
  23. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterollowering therapy on the coronary endothelium in patients with coronary artery disease. NEJM. 1995;332:481–487
  24. Anderson TJ, Meredith IT, Yeung AC, et al. The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. NEJM. 1995;332:488–493
  25. Egashira K, Hirooka Y, Kai H, et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994;89:2519–2524
  26. Tsurumi Y, Nagashima H, Ichikawa K, et al. Influence of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine. J Am Coll Cardiol. 1995;26:1242–1250
  27. Cooper RS, Ford E. Coronary heart disease among blacks and whites in the NHANES-1 epidemiologic follow-up study: Incidence of new events and risk factor prevention. Circulation. 1990;81:723–730
  28. Harris M, Hadden W, Knowler W, Bennett P. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20–74 years. Diabetes. 1987;36:523–534
  29. Houghton JL, Carr AA, Prisant LM, et al. Morphologic, hemodynamic, and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia. Am J Cardiol. 1992;69:219–224
  30. Johnstone MT, Creager SJ, Scales KM, et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510–2516
  31. Zoneraich S, Siverman G, Zoneraich O. Primary myocardial disease, diabetes mellitus, and small vessel disease. Am Heart J. 1980;100:754–755
  32. Dawson D. Ethnic differences in female overweight: Data from the National Health Interview Survey. Am J Public Health. 1988;78:1326–1329
  33. Gillum R. Overweight and obesity in black women: A review of published data from the National Center for Health Statistics. J Natl Med Assoc. 1987;79:865–871
  34. de Simone G, Devereux RB, Roman MJ, et al. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994;23:600–606
  35. Lauer MS, Anderson KM, Levy D. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The Framingham Heart Study. J Am Coll Cardiol. 1992;19:130–134
  36. Nissen SE, Gurley JC, Grines CL, et al. Intravascular ultrasound assessment of human size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 1991;84:1087–1099
  37. Egashira K, Inou T, Hirooka Y, et al. Evidence of impaired endotheliumdependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. NEJM. 1993;328:1659–1664
  38. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–476
  39. Reis SE, Gloth ST, Blumenthal RS, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 1994;89:52–60
  40. Wilson RF, Laughlin DE, Ackell PH, et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation. 1985;72:82–92
  41. Sibley DH, Millar HD, Hartley CJ, Whitlow PL. Subselective measurement of coronary blood flow velocity using a steerable Doppler catheter. J Am Coll Cardiol. 1986;8:1332–1340
  42. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium-dependent vasodilation: mechanisms of acetylcholine effect on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation. 1989;79:1043–1051
  43. Christensen CW, Rosen LB, Gal RA, et al. Coronary vasodilator reserve: Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism. Circulation. 1991;83:294–303

** Supported by Grant HL50262 from the National Heart, Lung, and Blood Institute, Bethesda, MD.

PII: S0002-9343(96)00449-4

doi: 10.1016/S0002-9343(96)00449-4

The American Journal of Medicine
Volume 102, Issue 3 , Pages 245-251 , March 1997

Article Tools